DGAP-News: CureVac / Key word(s): Alliance/Contract
CureVac Establishes European-Based Network to Ramp Up Manufacturing of its COVID-19 Vaccine Candidate, CVnCoV
- Building an integrated European vaccine manufacturing network with experienced partners
- Managing supply chain risk by collaborating with several partners for each manufacturing step
- Increasing capacity to reach up to 300 million doses in 2021 and up to 600 million doses in 2022
CureVac aims to build a broad and integrated European vaccine manufacturing network with highly experienced CDMO (Contract Development and Manufacturing Organization) partners for each of the key manufacturing steps for CVnCoV. With this strategy, the company is expecting to significantly increase its existing manufacturing capacities for CVnCoV to up to 300 million doses in 2021 and up to 600 million doses in 2022, while managing potential supply chain risks. An additional large-scale production facility supported by the European Investment Bank (EIB) at CureVac's headquarters in Tübingen is currently in development.
"It is our goal to ramp up the production capacity of our vaccine candidate within a short period of time to ensure a stable supply," said Dr. Florian von der Mülbe, Chief Production Officer of CureVac. "We are currently working with experienced CDMOs across Europe to establish a solid production network. Geographic proximity is an important factor for facilitating alignment and technology transfers."
Over the coming weeks, CureVac expects to announce key CDMO and supplier partnerships. CureVac's CVnCoV manufacturing network will leverage expertise and capacity across Germany, France, the Netherlands, Belgium, Spain and Austria, as well as potentially Sweden, Poland, Italy and Ireland.
CureVac Media Contact
CureVac Investor Relations Contact
For further information, please reference the company's reports and documents filed with the U.S. Securities and Exchange Commission (SEC). You may get these documents by visiting EDGAR on the SEC website at www.sec.gov.
17.11.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.